Pharmacological inhibition of ATGL as therapeutic approach for MASH: Far beyond the lipase suppression role of ATGL inhibitors

Abstract

Section snippets

Declaration of Competing Interest

The authors disclose no conflicts.

Financial support

This work was supported by the National Natural Science Foundation of China (No. 82004062), the Young Elite Scientists Sponsorship Program by CACM (No. 2021-QNRC2-B12)

Authors contributions

TY: initial drafting of the manuscript. YH: revision of the manuscript. ML: conception and revision and final approval of the manuscript. All the authors approved the final version of the letter.